Month: March 2025

Reminder of Annual General Meeting of Shareholders TORONTO, March 25, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) plans to release its first quarter 2025 financial results on Wednesday, April 23, 2025, before North American financial markets open. The results will be distributed by newswire and posted at investors.rogers.com. Rogers’ management will host its quarterly teleconference with the investment community to discuss the results and outlook at 8:00 a.m. ET. A live webcast of the teleconference will be available on the Investor Relations section of Rogers’ website at investors.rogers.com. Alternatively, the teleconference can be accessed by dialing 416-639-5883 (1-844-282-4459 toll free for North America). When prompted, callers are required to enter passcode 3793238# for admittance...

PASCAGOULA, Miss., March 25, 2025 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Ingalls Shipbuilding division successfully launched future USS Jeremiah Denton (DDG 129) today, the third Flight III Arleigh Burke-class destroyer to be built at the shipyard. Shipbuilders transferred DDG 129 from land to the company’s dry dock using translation railcars to support the ship during the move. Once in the dry dock, the ship was floated and moved by tugboats to a pier at the shipyard. “The launch of DDG 129 is a testament to the hard work and dedication of our Ingalls shipbuilders and a collaborative achievement with our Navy partners,” Ingalls Shipbuilding DDG Program Manager Ben Barnett said. “The future USS Jeremiah Denton will now undergo final outfitting, systems activation, and testing before entering the fleet.” DDG 129 is named for former...

New, improved formulation set to replace EGRIFTA SV® MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin for injection. The Company will commercialize the new formulation under the tradename EGRIFTA WR™. Tesamorelin for injection is the only medication approved in the U.S. for the reduction of excess abdominal fat in adults with HIV who have lipodystrophy. The new formulation, EGRIFTA WR™, is a daily injectable but only needs weekly reconstitution. It requires less than half the administration volume as the current...

LONDON, March 25, 2025 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces that it has filed its Annual Report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission. Form 20-F can be downloaded using the link below and is available on our website (www.navigatorgas.com) in the ‘Investors Centre’ section under ‘Financials’ then ‘SEC Filings’. Shareholders may request a hard copy at no cost using the contact details listed below. 2024 Form 20-F Annual Report About Navigator GasNavigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) is the owner and operator of the world’s largest fleet of handysize liquefied...

Company AnnouncementRepurchase of up to 2.2 million shares with a maximum aggregate total value of DKK 4.0 billion Reduce the capital of Genmab and honor our commitments under the Restricted Stock Unit program Completion expected no later than July 10, 2025COPENHAGEN, Denmark; March 25, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that it is initiating a share buy-back program, to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Time frame The share buy-back program will start on March 26, 2025, and is expected to end no later than July 10, 2025 (unless...

GUELPH, Ontario, March 25, 2025 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS” or “Company”) (TSX: HPS.A) today announced the retirement of Grant Robinson from the board of directors of the Company, effective March 25, 2025. Grant was originally scheduled to retire at the upcoming shareholders meeting of the Company on May 8, 2025, but was recently diagnosed with a significant health issue that will require his immediate time and focus. The Board acknowledges and thanks Grant for an incredible 18 years of service to the Company.  His passion, business acumen and warm communication style helped build HPS into the great company it is today. Fred Jaques will immediately assume the lead director role and HPS expects to be adding two new independent directors to its board at its upcoming shareholder meeting on May 8, 2025. Caution...